KRAS and invasive ductal breast carcinoma: Although the WHO classification of MCP is based on morphological characteristics such as pushing growth of highly pleomorphic carcinoma cells, including syncytial cells, no specific markers have been identified that distinguish KRAS-mutant MCP from undifferentiated/poorly differentiated ductal adenocarcinomas.